Patient and Public Involvement
SECONDARY, RECURRENCE
Patient and Public Involvement (PPI) representatives provided input to the trial design including feedback on the importance of the research question, the effect size used in the power calculation and ideas on how to make participation in the trial appealing to potential recruits, and requested addition of the secondary outcome of time to recurrence of symptoms. They also reviewed all participant-facing documents prior to the ethics submission. PPI representatives sat on the Trial Steering Committee as independent members and contributed to oversight of the trial including review and interpretation of the results.